Literature DB >> 6199198

The Shigella flexneri O-antigenic polysaccharide chain. Nature of the biological repeating unit.

N I Carlin, A A Lindberg, K Bock, D R Bundle.   

Abstract

The sequence of monosaccharides in the biological repeating tetrasaccharide unit of Shigella flexneri variant Y O-antigenic polysaccharide chain was determined by subjecting three oligosaccharides of the polysaccharide, obtained by phage-Sf6-mediated enzymatic hydrolysis, to methylation analysis and proton nuclear magnetic resonance spectroscopy. The smallest saccharide was shown to be a tetrasaccharide with the structure alpha-L-Rhap-(1-2)-L-Rha. The next saccharide, an octasaccharide, was shown to be a dimer of the tetrasaccharide with the L-Rha residues linked alpha 1.3. The longest saccharide was shown to be a decasaccharide with the following structure: alpha-L-Rhap-(1-2)-alpha-L-Rhap-(1-3)-alpha-L-Rhap-(1- 3)-beta-D-GlcpNAc-(1-2)-alpha-L-Rhap-(1-2)-alpha-L-Rhap++ + +-(1-3)-alpha-L-Rhap-(1-3)-beta-D-GlcpNAc-(1-2)-alpha-L-R hap-(1-2)-L-Rha. Thus the decasaccharide differed from the octasaccharide and tetrasaccharide by having the alpha-L-Rhap-(1-2)-L-Rhap disaccharide added in the terminal non-reducing end of the saccharide chain. This shows that the alpha-L-Rhap-(1-2)-alpha-L-Rhap-(1-3)-alpha-L-Rhap-(1- 3)-D-GlcpNAc tetrasaccharide is the biological repeating unit of the O chain and that the repeating units are joined through a beta-D-GlcpNAc-(1-2)-L-Rhap linkage. Inhibition experiments utilizing the enzyme-linked immunosorbent assay (ELISA) with S. flexneri Y lipopolysaccharide/S. flexneri Y rabbit antiserum showed that the decasaccharide was the best inhibitor (threefold as active as the octasaccharide and sixtyfold as active as the tetrasaccharide); this supports the postulated structure of the biological repeating unit.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199198     DOI: 10.1111/j.1432-1033.1984.tb07993.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Shigella flexneri O-antigen epitopes: chemical and immunochemical analyses reveal that epitopes of type III and group 6 antigens are identical.

Authors:  N I Carlin; T Wehler; A A Lindberg
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

2.  Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a.

Authors:  A B Hartman; L L Van de Verg; C R Mainhart; B D Tall; S J Smith-Gill
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

3.  Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.

Authors:  D Pavliakova; C Chu; S Bystricky; N W Tolson; J Shiloach; J B Kaufman; D A Bryla; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh.

Authors:  K A Talukder; D K Dutta; A Safa; M Ansaruzzaman; F Hassan; K Alam; K M Islam; N I Carlin; G B Nair; D A Sack
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice.

Authors:  D Pavliakova; J S Moncrief; D M Lyerly; G Schiffman; D A Bryla; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Structural analysis of novel rhamnose-branched oligosaccharides from the glycophosphosphingolipids of Leptomonas samueli.

Authors:  J O Previato; R Wait; C Jones; L Mendonça-Previato
Journal:  Glycoconj J       Date:  1994-02       Impact factor: 2.916

7.  Identification of newly recognized serotype 1c as the most prevalent Shigella flexneri serotype in northern rural Vietnam.

Authors:  R M Stagg; P D Cam; N K Verma
Journal:  Epidemiol Infect       Date:  2007-10-09       Impact factor: 2.451

8.  Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptide.

Authors:  Silvia Borrelli; Rehana B Hossany; B Mario Pinto
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

9.  Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh.

Authors:  Kaisar A Talukder; M Aminul Islam; Dilip K Dutta; Ferdaus Hassan; Ashrafus Safa; G B Nair; David A Sack
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V, and VI antigens, group 3,4 antigen, and an epitope common to all Shigella flexneri and Shigella dysenteriae type 1 stains.

Authors:  N I Carlin; A A Lindberg
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.